Heyholder
‹ Activism Filings

Rznomics Inc. Q3 operating loss of KRW 6.9 billion; cumulative operating loss of KRW 21.8 billion

Rznomics Inc.· Periodic Report

AI summary · Not investment advice

Algenomics sold KRW 0.4 billion in Q3 and lost KRW 6.9 billion from its main business, with a KRW 21.8 billion loss from January to September.

Operating profit · 3 months

KRW -6.9 billion

Key facts

Revenue (3 months)
KRW 448.7 million
Net income (3 months)
KRW -6.4 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 0
Revenue (year to date)
KRW 1.6 billion
Operating profit (prior-year 3 months)
KRW -8.1 billion
Operating profit (year to date)
KRW -21.8 billion
Net income (prior-year 3 months)
KRW -8.1 billion
Net income (year to date)
KRW -20.6 billion

Commentary

AI commentary · Not investment advice

What happened

Rgenomics filed its quarterly report for the third quarter of 2026, on a consolidated basis. Sales for the latest 3 months were KRW 448.7 million. Sales for the same 3 months a year earlier were KRW 0. Cumulative sales this year were KRW 1.62 billion.

In the company's terms

Operating profit (money earned from the core business) was a loss of KRW 6.91 billion for the latest 3 months. A year earlier, the same period showed a loss of KRW 8.08 billion. The cumulative operating loss this year is KRW 21.82 billion.

What changes for shareholders

Net income (the final profit after taxes and all other items) was a loss of KRW 6.44 billion for the latest 3 months. A year earlier, the same period showed a loss of KRW 8.15 billion. The cumulative net loss this year is KRW 20.57 billion.

Comments

No comments yet

Comments from shareholders will appear here.